Fractyl Health Inc.
Fractyl Health Inc. (GUTS): 4 pipeline candidates · 1 upcoming catalyst · ~9 mo cash runway · 4 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
9.0 months
D/E 3.65 · 0% dilution
Lead: Phase 3
4 candidates
1 upcoming, next in ~104d
N/A
A transparent, data-derived signal for Fractyl Health Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$123.1M
Cash
$67.4M
Quarterly Burn
$22.5M
Runway
9.0 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
| Drug | Phase |
|---|---|
| revita | Phase 3 |
| revita dmr system | Phase 3 |
| rjva-001 | Preclinical |
| rjva-002 | Preclinical |
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
78
Total value held
$19.3M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 11,066,012 | $5.1M |
| 683 capital management, llc | 6,727,235 | $3.1M |
| maverick capital ltd | 3,974,806 | $1.8M |
| blackrock, inc. | 2,139,837 | $980K |
| m28 capital management lp | 1,856,117 | $850K |
| silverarc capital management, llc | 1,701,625 | $779K |
| ubs group ag | 1,622,163 | $743K |
| geode capital management, llc | 1,435,261 | $657K |
| adar1 capital management, llc | 1,428,571 | $654K |
| cm management, llc | 1,400,000 | $641K |
Showing top 10 of 78 institutional holders of Fractyl Health Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Fractyl Health Inc.'s pipeline?
Fractyl Health Inc. (GUTS) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Fractyl Health Inc.'s lead drug candidate?
Fractyl Health Inc.'s most advanced tracked candidate is revita (Phase 3) for Weight maintenance in people with obesity who discontinue GLP-1 based therapy.
What is Fractyl Health Inc.'s next catalyst?
Fractyl Health Inc.'s next tracked catalyst is a Phase2_Topline event — "Phase 2 Readout: revita" — expected September 30, 2026.
What is Fractyl Health Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Fractyl Health Inc. has approximately 9.0 months of cash runway.
What is Fractyl Health Inc.'s market capitalization?
Fractyl Health Inc.'s market capitalization is approximately $123.1M.
Get the full picture on Fractyl Health Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.